ANIXA BIOSCIENCES INC Share Holder Equity 2010-2022 | ANIX
ANIXA BIOSCIENCES INC share holder equity from 2010 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
ANIXA BIOSCIENCES INC Annual Share Holder Equity
(Millions of US $) |
| 2021 |
$35 |
| 2020 |
$8 |
| 2019 |
$5 |
| 2018 |
$5 |
| 2017 |
$8 |
| 2016 |
$1 |
| 2015 |
$5 |
| 2014 |
$4 |
| 2013 |
$-3 |
| 2012 |
$-1 |
| 2011 |
$1 |
| 2010 |
$5 |
| 2009 |
$4 |
ANIXA BIOSCIENCES INC Quarterly Share Holder Equity
(Millions of US $) |
| 2022-04-30 |
$31 |
| 2022-01-31 |
$33 |
| 2021-10-31 |
$35 |
| 2021-07-31 |
$36 |
| 2021-04-30 |
$37 |
| 2021-01-31 |
$13 |
| 2020-10-31 |
$8 |
| 2020-07-31 |
$8 |
| 2020-04-30 |
$5 |
| 2020-01-31 |
$5 |
| 2019-10-31 |
$5 |
| 2019-07-31 |
$5 |
| 2019-04-30 |
$6 |
| 2019-01-31 |
$5 |
| 2018-10-31 |
$5 |
| 2018-07-31 |
$6 |
| 2018-04-30 |
$6 |
| 2018-01-31 |
$6 |
| 2017-10-31 |
$8 |
| 2017-07-31 |
$5 |
| 2017-04-30 |
$4 |
| 2017-01-31 |
$-4 |
| 2016-10-31 |
$1 |
| 2016-07-31 |
$2 |
| 2016-04-30 |
$3 |
| 2016-01-31 |
$4 |
| 2015-10-31 |
$5 |
| 2015-07-31 |
$6 |
| 2015-04-30 |
$7 |
| 2015-01-31 |
$8 |
| 2014-10-31 |
$4 |
| 2014-07-31 |
$0 |
| 2014-04-30 |
$-5 |
| 2014-01-31 |
$-6 |
| 2013-10-31 |
$-3 |
| 2013-07-31 |
$-3 |
| 2013-04-30 |
$-1 |
| 2013-01-31 |
$-1 |
| 2012-10-31 |
$-1 |
| 2012-07-31 |
$-1 |
| 2012-04-30 |
$-0 |
| 2012-01-31 |
$1 |
| 2011-10-31 |
$1 |
| 2011-07-31 |
$2 |
| 2011-04-30 |
$3 |
| 2011-01-31 |
$3 |
| 2010-10-31 |
$5 |
| 2010-07-31 |
$3 |
| 2010-04-30 |
$5 |
| 2010-01-31 |
$4 |
| 2009-10-31 |
$4 |
| 2009-07-31 |
$3 |
| 2009-04-30 |
$1 |
| 2009-01-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.091B |
$0.001B |
|
Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.
|
